Gsk (GSK) Dividends Paid - Common (2009 - 2026)

Gsk (GSK) has 18 years of Dividends Paid - Common data on file, last reported at -$1.8 billion in Q3 2026.

• For the quarter ending Q3 2026, Dividends Paid - Common changed N/A year-over-year to -$1.8 billion; the trailing twelve-month figure through Sep 2026 stood at -$4.5 billion (changed N/A YoY), and the FY2025 full-year result was -$3.4 billion, down 9.17% from the prior year.
• Dividends Paid - Common was -$1.8 billion for Q3 2026 at Gsk, down from -$866.9 million in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of -$72.2 million in Q3 2023 to a low of -$2.5 billion in Q4 2022.
• A 5-year average of -$800.8 million and a median of -$697.6 million in 2023 frame the typical range for Dividends Paid - Common.
• Across the five-year window, Dividends Paid - Common plunged 58.34% in 2022 and jumped 71.24% in 2023, its largest moves.
• Gsk's Dividends Paid - Common stood at -$2.5 billion in 2022, then soared by 44.18% to -$1.4 billion in 2023, then fell by 13.46% to -$1.6 billion in 2024, then decreased by 7.71% to -$1.7 billion in 2025, then decreased by 9.06% to -$1.8 billion in 2026.
• Per Business Quant data, the three most recent Dividends Paid - Common figures were -$1.8 billion in Q3 2026, -$866.9 million in Q1 2026, and -$1.7 billion in Q4 2025.